
DOI: 10.1055/s-0040-1716610
Infective Endocarditis: A Case Series

Abstract
Infective endocarditis (IE) is an infection of the endocardial surface of the heart. The incidence of IE worldwide is approximately 3 to 10 per 100,000 people annually. Twenty percent of patients die during the hospital stay, and the mortality may reach 25 to 30% six months postinfection. We hereby present our experience of six patients, of whom five survived. The cause of one death was late presentation and lack of coverage for Burkholderia in the prescribed empirical antibiotic therapy. One of our patients, with culture-negative endocarditis, responded to doxycycline and did not require any surgery. Five out of six patients who underwent surgery had vegetations more than 10 mm in size, and one patient had an aortic valve abscess (caused by Staphylococcus haemolyticus). Both prosthetic endocarditis and native valve endocarditis can be treated successfully with antimicrobial agents and surgery (when indicated). A high index of suspicion is required to diagnose IE caused by fungus and atypical bacteria.
Publikationsverlauf
Publikationsdatum:
10. September 2020 (online)
© 2020. Official Publication of The Simulation Society (TSS), accredited by International Society of Cardiovascular Ultrasound ISCU. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
References
- 1 Pant S, Patel NJ, Deshmukh A. et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015; 65 (19) 2070-2076
- 2 Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One 2013; 8 (03) e60033
- 3 Federspiel JJ, Stearns SC, Peppercorn AF. Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 2012; 172 (04) 363-365
- 4 Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet 2015; 385 (9974) 1219-1228
- 5 Cabell CH, Jollis JG, Peterson GE. et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002; 162 (01) 90-94
- 6 Math RS, Sharma G, Kothari SS. et al. Prospective study of infective endocarditis from a developing country. Am Heart J 2011; 162 (04) 633-638
- 7 Garg N, Kandpal B, Garg N. et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992-2001. Int J Cardiol 2005; 98 (02) 253-260
- 8 Choudhury R, Grover A, Varma J. et al. Active infective endocarditis observed in an Indian hospital 1981-1991. Am J Cardiol 1992; 70 (18) 1453-1458
- 9 Selton-Suty C, Célard M, Le Moing V. et al. AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012; 54 (09) 1230-1239
- 10 Leone S, Ravasio V, Durante-Mangoni E. et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection 2012; 40 (05) 527-535
- 11 Nadji G, Rusinaru D, Rémadi JP, Jeu A, Sorel C, Tribouilloy C. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail 2009; 11 (07) 668-675
- 12 Olmos C, Vilacosta I, Fernández C. et al. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J 2013; 34 (26) 1999-2006
- 13 García-Cabrera E, Fernández-Hidalgo N, Almirante B. et al. Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases, Spanish Network for Research in Infectious Diseases. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 2013; 127 (23) 2272-2284
- 14 Tattevin P, Revest M, Lefort A, Michelet C, Lortholary O. Fungal endocarditis: current challenges. Int J Antimicrob Agents 2014; 44 (04) 290-294
- 15 Smego Jr RA, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore) 2011; 90 (04) 237-249
- 16 Thuny F, Beurtheret S, Mancini J. et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011; 32 (16) 2027-2033
- 17 Hoen B, Alla F, Selton-Suty C. et al. Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288 (01) 75-81
- 18 Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med 2013; 368 (15) 1425-1433
- 19 Tornos P, Iung B, Permanyer-Miralda G. et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005; 91 (05) 571-575
- 20 Chu VH, Cabell CH, Benjamin DK Jr. et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109 (14) 1745-1749
- 21 San Román JA, López J, Vilacosta I. et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med 2007; 120 (04) 369.e1-369.e7
- 22 Murdoch DR, Corey GR, Hoen B. et al. International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169 (05) 463-473
- 23 Yew HS, Murdoch DR. Global trends in infective endocarditis epidemiology. Curr Infect Dis Rep 2012; 14 (04) 367-372
- 24 Nigo M, Munita JM, Arias CA, Murray BE. What’s new in the treatment of enterococcal endocarditis?. Curr Infect Dis Rep 2014; 16 (10) 431
- 25 Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med 1997; 48: 25-33
- 26 Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001; 14 (01) 177-207
- 27 Baddley JW, Benjamin Jr DK, Patel M. et al. International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS). Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008; 27 (07) 519-529
- 28 Habib G, Lancellotti P, Antunes MJ. et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36 (44) 3075-3128
- 29 Baddour LM, Wilson WR, Bayer AS. et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132 (15) 1435-1486
- 30 Pettersson GB, Hussain ST, Coselli JS. et al. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg 2019; 8 (06) 630-644
- 31 Li JS, Sexton DJ, Mick N. et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30 (04) 633-638